title: Clinical characteristics and treatment outcomes of adolescent heroin users.
abstract: Heroin use among adolescents is a major social and health problem, and has been increasing over the past decade, but has not been extensively studied. This study compared characteristics of adolescent heroin users (n = 56) to adolescent non heroin users (n = 93) at entry to short-term residential treatment through 12 months posttreatment. The heroin group was comprised of more females, older adolescents, and more Caucasians. At baseline, heroin users reported more days of drug use, days high, days not meeting responsibilities, and had more substance abuse and dependence symptoms. Heroin users also showed greater severity on multiple indicators of functional impairment and psychological distress. Although adolescent heroin users appear to represent a distinct subpopulation with multiple indicators of heightened severity, they respond to treatment with significant reductions in drug use, psychological symptoms, illegal activities, and overall psychosocial impairment. Furthermore, adolescent heroin users respond to treatment in the same remitting/relapsing pattern as non heroin users, yet their higher severity persists over a 12 month follow-up period. Further research is needed to generalize these findings to other settings, and to guide the development and evaluation of treatment options for adolescent heroin users.
authors.affiliation: Potomac Healthcare Foundation, 3800 Frederick Avenue, Baltimore, Maryland 21229, USA.
authors.forename: Philip
authors.initials: P
authors.lastname: Clemmey
authors.forename: Lynda
authors.initials: L
authors.lastname: Payne
authors.forename: Marc
authors.initials: M
authors.lastname: Fishman
mesh_terms: D000293:Adolescent; D000704:Analysis of Variance; D005260:Female; D005500:Follow-Up Studies; D006556:Heroin Dependence / Q000453:epidemiology* / Q000523:psychology / Q000628:therapy*; D006801:Humans; D008297:Male; D016320:Substance Abuse Treatment Centers / Q000706:statistics & numerical data*; D016896:Treatment Outcome